Aligos Therapeutics

ALGS

Capitalización de mercado USD 16.1 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 EcoR1 Capital San Francisco, California	USD 3.83 M	–	–	–
2	2 Vivo Capital Palo Alto, California	USD 3.44 M	–	–	–
3	3 Tang Capital Management San Diego, California	USD 3.23 M	-USD 103 k	-3,830	-3%
4	4 Versant Venture Management San Francisco, California	USD 2.25 M	–	–	–
5	5 HHLR Advisors Grand Cayman, Cayman Islands	USD 2.24 M	–	–	–
6	BBA 6 Baker Bros. Advisors New York	USD 2.02 M	–	–	–
7	7 Adage Capital Partners Boston, Massachusetts	USD 1.19 M	–	–	–
8	8 Bank of America Charlotte, North Carolina	USD 1.12 M	+USD 3.41 k	+127	+0.3%
9	9 Vanguard Group Malvern, Pennsylvania	USD 966 k	-USD 23.6 k	-879	-2%
10	NM 10 Newtyn Management New York	USD 874 k	-USD 130 k	-4,858	-12%
11	11 Royal Bank of Canada Toronto, Ontario, Canada	USD 816 k	+USD 854 k	+31,827	+1,779%
12	12 Pivotal bioVenture Partners Investment Advisor San Francisco, California	USD 722 k	–	–	–
13	13 Silverarc Capital Management Boston, Massachusetts	USD 614 k	–	–	–
14	14 Acadian Asset Management Boston, Massachusetts	USD 547 k	–	–	–
15	15 Renaissance Technologies New York	USD 418 k	-USD 23.9 k	-892	-5%
16	16 BlackRock New York	USD 292 k	-USD 7.64 k	-285	-2%
17	17 Geode Capital Management Boston, Massachusetts	USD 249 k	+USD 60.9 k	+2,270	+28%
18	18 Millennium Management New York	USD 171 k	-USD 244 k	-9,100	-56%
19	19 State Street Boston, Massachusetts	USD 94.6 k	–	–	–
20	20 Bridgeway Capital Management Houston, Texas	USD 89.3 k	–	–	–
21	21 Deutsche Bank Frankfurt Am Main Ge, Germany	USD 69.2 k	–	–	–
22	22 Two Sigma Advisers New York	USD 50.9 k	-USD 27.7 k	-1,032	-33%
23	23 Northern Trust Chicago, Illinois	USD 38.2 k	–	–	–
24	24 Charles Schwab San Francisco, California	USD 30.5 k	+USD 33.7 k	+1,255	Nuevas
25	25 Two Sigma Investments New York	USD 28.3 k	-USD 29.7 k	-1,107	-49%

Aligos Therapeutics ALGS Capitalización de mercado USD 16.1 M

Aligos Therapeutics

ALGS

Capitalización de mercado USD 16.1 M